421
Views
10
CrossRef citations to date
0
Altmetric
Plenary Paper

Flow analysis of individual blood extracellular vesicles in acute coronary syndrome

, , , , , & show all
Pages 165-173 | Received 16 Mar 2016, Accepted 05 Jul 2016, Published online: 05 Sep 2016

References

  • Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13:269–288. doi:10.1111/j.1365-2141.1967.tb08741.x.
  • Owens AP, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011;108:1284–1297. doi:10.1161/CIRCRESAHA.110.233056.
  • Rautou P-E, Vion A-C, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011;109:593–606. doi:10.1161/CIRCRESAHA.110.233163.
  • Ayers L, Harrison P, Kohler M, Ferry B. Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity. J Extracell Vesicles 2014:25348-25356, http://dx.doi.org/10.3402/jev.v3.25348
  • Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost. 2013;11:24–35. doi:10.1111/jth.12268.
  • Leroyer AS, Tedgui A, Boulanger CM. Role of microparticles in atherothrombosis. J Intern Med. 2008;263:528–537. doi:10.1111/j.1365-2796.2008.01957.x.
  • Nomura S, Shimizu M. Clinical significance of procoagulant microparticles. J Intensive Care 2015;3:2. doi:10.1186/s40560-014-0066-z.
  • Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita L F, Théry C, Raposo G. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126:5553–5565. doi:10.1242/jcs.128868.
  • Aatonen MT, Öhman T, Nyman TA, Laitinen S, Grönholm M, Siljander PR-M. Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 2014;3:1–15. doi:10.3402/jev.v3.24692.
  • Besancenot R, Chaligné R, Tonetti C, Pasquier F, Marty C, Lécluse Y, Vainchenker W, Constantinescu SN, Giraudier S. A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation. PLoS Biol. 2010;8. doi:10.1371/journal.pbio.1000476.
  • Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, E. Ho J, et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014:1–8. doi:10.1093/eurheartj/ehu153.
  • Li P, Qin C. Elevated Circulating VE-Cadherin+CD144+Endothelial microparticles in ischemic cerebrovascular disease. Thromb Res. 2015;135:375–381. doi:10.1016/j.thromres.2014.12.006.
  • Hu S-S, Zhang H-G, Zhang Q-J, Xiu R-J. Small-Size Circulating endothelial microparticles in coronary artery disease. PLoS One 2014;9:e104528. doi:10.1371/journal.pone.0104528.
  • Wahl P, Jansen F, Achtzehn S, Schmitz T, Bloch W, Mester J, Werner N. Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLoS One 2014;9. doi:10.1371/journal.pone.0096024.
  • Jung C, Sörensson P, Saleh N, Arheden H, Rydén L, Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012;221:226–231. doi:10.1016/j.atherosclerosis.2011.12.025.
  • Takeshita J, Mohler ER, Krishnamoorthy P, Moore J, Rogers WT, Zhang L, Gelfand JM, Mehta NN. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. J Am Heart Assoc. 2014;3:1–8. doi:10.1161/JAHA.113.000507.
  • Dragovic R a, Southcombe JH, Tannetta DS, Redman CWG, Sargent IL. Multicolor flow cytometry and nanoparticle tracking analysis of extracellular vesicles in the plasma of normal pregnant and pre-eclamptic women. Biol Reprod. 2013; 89:151. doi:10.1095/biolreprod.113.113266.
  • Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011;31:27–33. doi:10.1161/ATVBAHA.110.218123.
  • György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger É, Pap E, Kittel Á, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667–2688. doi:10.1007/s00018-011-0689-3.
  • Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2013;44:11–19. doi:10.1007/s12020-012-9839-0.
  • Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res. 2012;43:31–35. doi:10.1016/j.arcmed.2012.01.006.
  • Skeppholm M, Mobarrez F, Malmqvist K, Wallén H. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost. 2012;107:1122–1129. doi:10.1160/TH11-11-0779.
  • van der Pol E, Coumans FAW, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, Sturk A, van Leeuwen TG, Nieuwland R. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12:1182–1192. doi:10.1111/jth.12602.
  • Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-‘t Hoen EN, Piper MG, Sivaraman S, Skog J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013;2. doi:10.3402/jev.v2i0.20360.
  • Arakelyan A, Ivanova O, Vasilieva E, Grivel J-C, Margolis L. Antigenic composition of single nano-sized extracellular blood vesicles. Nanomedicine Nanotechnology, Biol Med. 2015;11:489–498. doi:10.1016/j.nano.2014.09.020.
  • Kristian Thygesen, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Clin Biochem. 2013;46:1–4. doi:10.1016/j.clinbiochem.2012.10.036.
  • Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619. doi:10.1093/eurheartj/ehs215.
  • Hamm CW, Bassand J-P, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio. Eur Heart J. 2011;32:2999–3054. doi:10.1093/eurheartj/ehr236.
  • Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Caso P, Dudek D, Gielen S, Huber K, et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost. 2012;10:437–446. doi:10.1111/j.1538-7836.2011.04610.x.
  • Arakelyan A, Fitzgerald W, Margolis L, Grivel J. Technical advance nanoparticle-based flow virometry for the analysis of individual virions. J Clin Invest. 2013;123:3716–3727. doi:10.1172/JCI67042.3716.
  • Campbell EC, Antoniou AN, Powis SJ. The multi-faceted nature of HLA class I dimer molecules. Immunology 2012;136:380–384. doi:10.1111/j.1365-2567.2012.03593.x.
  • Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta - Mol Cell Biol Lipids 2014;1841:108–120. doi:10.1016/j.bbalip.2013.10.004.
  • Yuana Y, Sturk A, Nieuwland R. Extracellular vesicles in physiological and pathological conditions. Blood Rev. 2013;27:31–39. doi:10.1016/j.blre.2012.12.002.
  • Lovren F, Verma S. Evolving role of microparticles in the pathophysiology of endothelial dysfunction. Clin Chem. 2013;59:1166–1174. doi:10.1373/clinchem.2012.199711.
  • Helbing T. Role of microparticles in endothelial dysfunction and arterial hypertension. World J Cardiol. 2014;6:1135. doi:10.4330/wjc.v6.i11.1135.
  • Liu M-L, Williams KJ. Microvesicles. Curr Opin Endocrinol Diabetes Obes. 2012;19:121–127. doi:10.1097/MED.0b013e32835057e9.
  • Shan LY, Li JZ, Zu LY, Niu CG, Ferro A, Zhang YD, Zheng L-M, Ji Y. Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction. CNS Neurosci Ther. 2013;19:917–925. doi:10.1111/cns.12199.
  • Chou YIS, Kong J, Song R, Yan L, Zheng L, Zhang Y. Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. Biomarkers 2014;19:684–692. doi:10.3109/1354750X.2014.981293.
  • Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F, Capogrossi MC, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J. 2012;76:2174–2182. doi:10.1253/circj.CJ-12-0068.
  • Montoro-Garcia S, Shantsila E, Tapp LD, Lopez-Cuenca A, Romero AI, Hernandez-Romero D, Orenes-Piñero E, Manzano-Fernández S, Valdés M, Marín F, et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013;227:313–322. doi:10.1016/j.atherosclerosis.2013.01.028.
  • Kafian S, Mobarrez F, Wallén H, Samad B. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. Platelets 2014;7104:1–7. doi:10.3109/09537104.2014.940304.
  • Arderiu G, Pena E, Badimon L. Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation. Arterioscler Thromb Vasc Biol. 2014;35:348–357. doi:10.1161/ATVBAHA.114.303927.
  • Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, Grunebaum L, Ohlmann P, Freyssinet J-M, Bareiss P, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009;204:636–641. doi:10.1016/j.atherosclerosis.2008.10.039.
  • Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31 +/Annexin V + microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32:2034–2041. doi:10.1093/eurheartj/ehq478.
  • Kanhai D a., Visseren FLJ, Van Der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, Kappelle LJ, Uiterwaal CSPM, Lim SK, Sze SK, et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol. 2013;168:2358–2363. doi:10.1016/j.ijcard.2013.01.231.
  • Suades R, Padro T, Alonso R, Mata P, Badimon L. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost. 2013;110:366–377. doi:10.1160/TH13-03-0238.
  • Lins LCA, França CN, Fonseca FAH, Barbosa SPM, Matos LN, Aguirre AC, Bianco HT, do Amaral JB, Izar MC. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients. Cell Biochem Biophys. 2014. doi:10.1007/s12013-014-9973-9.
  • Andre F, Chaput N, Schartz NEC, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol. 2004;172:2126–2136.doi:10.4049/jimmunol.172.4.2126.
  • Lynch S, Santos SG, Campbell EC, Nimmo AMS, Botting C, Prescott A, Antoniou AN, Powis SJ. Novel MHC class I structures on exosomes. J Immunol. 2009;183:1884–1891. doi:10.4049/jimmunol.0900798.
  • Min P-K, Kim J-Y, Chung K-H, Lee BK, Cho M, Lee D-L, Hong S-Y, Choi E-Y, Yoon Y-W, Hong B-K, et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013;227:323–328. doi:10.1016/j.atherosclerosis.2013.01.032.
  • Patrono C, Renda G. Platelet activation and inhibition in unstable coronary syndromes. Am J Cardiol. 1997;80:17E–20E.
  • Harker LA, Ritchie JL. The role of platelets in acute vascular events. Circulation 1980;62:V13–V18.
  • Bulut D, Becker V, Mügge A. Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can J Physiol Pharmacol. 2011;89:239–244. doi:10.1139/y11-013.
  • Otero R, Elias T, Montes-Worboys A, Dawson G, Lampa R, Jara L, Scully M. Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosis. Blood Coagul Fibrinolysis 2011;22:628–629. doi:10.1097/MBC.0b013e32834689d0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.